Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00666146 · ClinicalTrials.gov registry record

Familial Schizophrenia and Spectrum Personality Disorders

A clinical trial, sponsored by University of Maryland, Baltimore.

Completed
Registry status
539
Enrollment target

NCT00666146: Completed study, sponsored by University of Maryland, Baltimore.

NCT00666146 is a clinical trial that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 539 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00666146 has completed, sponsored by University of Maryland, Baltimore.

COMPLETED
Registry status
539 participants
Enrollment target

Study Summary

We propose to recruit 150 case families (i.e., families with a schizophrenia proband), 150 control families, and 45 control subjects who exhibit schizophrenia spectrum personality symptoms in the absence of a family history of schizophrenia. Participants will undergo a number of clinical, electrophysiological, perceptual, and cognitive assessments. These data will be used to identify phenotypes likely to be associated with genetic risk for schizophrenia, and to determine how these phenotypes aggregate in families. Some of the analyses will focus on examining associations between candidate genes and these alternative phenotypes. Thus if we are not able to recruit relatives we may still collect these phenotypic data in probands and their genetic sample for future genotype/phenotype association studies. Testing procedures require a 10-12 hour time commitment and testing will be completed over 2 or more days. Participants will be asked to give a blood (or saliva if difficult to obtain blood sample for instance because of fear of blood draws), which will be stored for future genetic analyses.

Trial Details

FieldValue
Enrollment Target 539 participants
Start Date 2004-07
Est. Completion 2020-01
University of Maryland, Baltimore

560 total trials

What the finished NCT00666146 record still lists

NCT00666146 is an observational study that tracks outcomes without assigning an intervention. The registered 539 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00666146 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00666146 about?

NCT00666146 is a clinical study titled "Familial Schizophrenia and Spectrum Personality Disorders". We propose to recruit 150 case families (i.e., families with a schizophrenia proband), 150 control families, and 45 control subjects who exhibit schizophrenia spectrum personality symptoms in the absence of a family history of schizophrenia. Participants will undergo a number of clinical, electrophy...

What is the current status of trial NCT00666146?

This trial is currently completed. The enrollment target is 539 participants. The study started on 2004-07. Estimated completion is 2020-01.

Who is sponsoring clinical trial NCT00666146?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04557462 · 540 participants · Phase 3

    A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  • NCT04956640 · 540 participants · Phase 1

    Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

  • NCT05429892 · 540 participants · NA

    FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers

  • NCT05549297 · 540 participants · Phase 3

    Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00666146, the US trial registry maintained by the National Library of Medicine. NCT00666146 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.